The evolving landscape of immune-oncology and cancer therapy research is being profoundly reshaped by single-cell RNA sequencing technologies. With the ability to dissect the complexity of tumors at a single-cell level, this approach is crucial for understanding the diverse nature of tumor cells and their microenvironments. This deep dive into cellular heterogeneity is pivotal for advancing personalized medicine and targeted therapies.
Linda Xue, Ph.D., Principal Scientist, Data Science and Bioinformatics, Crown Bioscience
Join us as Dr. Linda Xue, an esteemed Principle Scientist at Crown Bioscience, shares her expertise in tumor model genomics, biomarker discovery, and NGS product design and software development. Since joining Crown Bioscience in 2015, Dr. Xue has been a vital contributor to the Data Science and Bioinformatics division. Her academic journey includes a Ph.D. in Molecular Biomedicine and an M.Sc. in Life Science Informatics from the University of Bonn, Germany, complemented by a B.Sc. in Bioengineering from Beihang University.
Your privacy is important to us.
We'll never share your information.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy
2024-01-23
2023-12-12
landing_page
OMICS Tech Talk